Clinical Trial Update: Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy [NA]

View source ↗

Summary

A multicenter MD Anderson trial investigates eliminating breast cancer surgery or radiotherapy in exceptional responders to neoadjuvant systemic therapy. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor Negative Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Estrogen Receptor Negative, HER2 Positive Breast Carcinoma | NA | Status: RECRUITING